Second-tier testing and pre-symptomatic detection of Cystic Fibrosis

The Arizona Department of Health Services is seeking a vendor to provide a reagent‑rental solution and associated laboratory services for second‑tier testing and pre‑symptomatic detection of cystic fibrosis as part of the state’s newborn‑screening program. The contract includes supplying a Luminex 200 (or equivalent) instrument, the xTAG CF 60‑kit reagents, preventive‑maintenance support, training, and full HIPAA‑compliant handling of protected health information. The award will be a firm‑fixed‑price, one‑year contract with optional extensions up to five years, and the vendor must meet strict performance, insurance, and regulatory requirements. • Provide a Luminex 200 system (or equivalent) with software, accessories, and a 10‑day delivery of reagents. • Deliver and maintain a reagent‑rental solution for the xTAG CF 60‑kit (≥ 60 CFTR variants, ≥ 99 % sensitivity & specificity). • Offer on‑site or virtual training, 24/7 technical support, and a Business Associate Agreement for HIPAA compliance. • Meet insurance minimums, E‑Verify, and prohibited‑technology restrictions; contract may be extended annually up to a total of five years.